Removed tumor tissues were subjected to immunohistochemical analysis, which showed that the expression of a cell proliferation maker, Ki-67, was lower in sh-PD-L1 mice treated with doxorubicin than in mice that received either the sh-PD-L1-alone or doxorubicin-alone group (Figure 5G). The gene discussed is MKI67; the disease is neoplasm.